Crossmark

Money back guarantee? A cost–benefit framework of performance-based agreements (PBAs) for the reimbursement of pharmaceuticals

Crossref DOI link: https://doi.org/10.1007/s40821-018-0107-y

Published Online: 2018-06-13

Published Print: 2019-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Carletto, A.

Cicchetti, A.

Coretti, S.

Moramarco, V.

Ruggeri, M.
License Information

Text and Data Mining valid from 2018-06-13
More Information

Article History

Received: 25 May 2017

Revised: 28 February 2018

Accepted: 5 April 2018

First Online: 13 June 2018